ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,727.60
-1.08%
S&P ASX All Technology
3,063.80
-1.27%
Brent Oil
81.965
0.00%
US Dollar vs AUD
1.50943
0.00%
Bitcoin
68,588.82
0.08%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. China Pharma Holdings Inc (CPHI)

  7. China Pharma Holdings Inc (CPHI) News

CPHI

China Pharma (CPHI)

China Pharma Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CPHI
DateTimeSourceHeadlineSymbolCompany
16/05/202406:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
09/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
24/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
24/02/202408:05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
15/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CPHIChina Pharma Holdings Inc
09/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
07/02/202408:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CPHIChina Pharma Holdings Inc
27/01/202409:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CPHIChina Pharma Holdings Inc
27/01/202409:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
13/01/202408:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CPHIChina Pharma Holdings Inc
13/01/202406:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CPHIChina Pharma Holdings Inc
22/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
20/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
30/11/202300:00PR Newswire (US)China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceAMEX:CPHIChina Pharma Holdings Inc
14/11/202308:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
08/11/202308:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CPHIChina Pharma Holdings Inc
28/10/202307:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:CPHIChina Pharma Holdings Inc
20/10/202307:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
04/10/202307:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
15/08/202305:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
09/08/202322:30PR Newswire (US)China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAMEX:CPHIChina Pharma Holdings Inc
13/05/202306:07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CPHIChina Pharma Holdings Inc
31/03/202307:56Edgar (US Regulatory)Annual Report (10-k)AMEX:CPHIChina Pharma Holdings Inc
30/03/202307:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
10/03/202308:07Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CPHIChina Pharma Holdings Inc
10/03/202308:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CPHIChina Pharma Holdings Inc
25/02/202308:07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
25/02/202308:05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
31/12/202208:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
29/12/202200:00PR Newswire (US)China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective MaskAMEX:CPHIChina Pharma Holdings Inc
 Showing the most relevant articles for your search:AMEX:CPHI

Your Recent History

ASX
XFL
S&P ASX 50
ASX
SUN
Suncorp
NASDAQ
MSFT
Microsoft
ASX
WBC
Westpac Banking
NYSE
KO
Coca Cola
FX
AUDUSD
AUD vs US Dollar
FX
AUDJPY
AUD vs Yen
ASX
WOW
Woolworths
ASX
XJO
S&P ASX 200
ASX
WPL
Woodside Petroleum
PM
XAUUSD
Gold vs US Dollar
ASX
ORG
Origin Energy
ASX
NCM
Newcrest Mining
ASX
AMP
AMP
NYSE
JPM
JP Morgan Chase
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved